Article
Targeted therapies in the medical management of craniopharyngioma.
Pituitary - 1 Jun 2022
Iglesias Pedro
Abstract excerpt
Craniopharyngioma (CP) is an intracranial benign tumor that behaves aggressively due to its location, infiltration of the surrounding nervous tissue and high capacity for recurrence. Treatment of choice is surgery followed or not by radiotherapy. Recent advances in molecular biology techniques and the better understanding of the genetic alterations of the two histological types of CP have open new therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
